Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study on Durvalumab and Stereotactic Body Radiotherapy for Patients with Early-Stage Non-Small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Finland Norway Sweden
  • Study of Amivantamab and Cetrelimab for Patients with Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    1 1 1
    Investigated drugs:
    Italy Poland Spain
  • Study Comparing Datopotamab Deruxtecan and Docetaxel for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Belgium France Germany Italy The Netherlands Poland +1
  • Study of Hydroxychloroquine Effects in Patients with Resectable Head and Neck Cancer or Non-small Cell Lung Cancer

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy
  • Study of Osimertinib and Savolitinib for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Previous Osimertinib Treatment

    Not recruiting

    2 1 1 1
    Investigated drugs:
    Italy Spain
  • Study on the Safety and Effectiveness of Azacitidine and Pembrolizumab for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer After Platinum Treatment

    Not recruiting

    2 1 1
    Investigated drugs:
    Italy
  • Study of Bemcentinib with Pembrolizumab, Carboplatin, and Pemetrexed for Patients with Advanced or Metastatic Non-Small Cell Lung Cancer with STK11 Mutation

    Not recruiting

    1 1 1 1
    Investigated diseases:
    France Greece Hungary Italy Poland Spain
  • Study of CYC140 oral medication for patients with advanced solid tumors and lymphoma

    Not recruiting

    1 1 1
    Spain
  • Study for Patients with Advanced Non-Small Cell Lung Cancer Worsened by Osimertinib Treatment, Using Selumetinib and Drug Combination

    Not recruiting

    2 1 1 1
    Investigated diseases:
    Italy The Netherlands Norway Spain Sweden
  • Study of Durvalumab and Chemotherapy for Patients with Resectable Non-Small Cell Lung Cancer

    Not recruiting

    3 1 1 1
    Investigated diseases:
    Austria Belgium France Germany Hungary Italy +3